Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
about
Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@en
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@nl
type
label
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@en
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@nl
prefLabel
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@en
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@nl
P2093
P1476
Evaluation of BM-573, a novel ...... ocardial ischemia-reperfusion.
@en
P2093
Alexandre Ghuysen
Bernard Lambermont
Bernard Masereel
David Magis
Jean-Michel Dogne
Michel Pétein
Patrick Segers
Philippe Kolh
Stéphanie Rolin
Vincent D'Orio
P356
10.1016/J.PROSTAGLANDINS.2005.10.002
P577
2005-12-22T00:00:00Z